Major depressive disorder is associated with cardiovascular risk factors and low omega-3 index

Journal of Clinical Psychiatry

Volumn 72, Issue 9, 2011, Pages 1242-1247

  Baghai, Thomas C ^a   Varallo Bedarida, Gabriella ^b   Born, Christoph ^a   Häfner, Sibylle ^a   Schüle, Cornelius ^a   Eser, Daniela ^a   Rupprecht, Rainer ^a,c   Bondy, Brigitta ^a   Von Schacky, Clemens ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CHOLESTEROL; GLUCOSE; INTERLEUKIN 6; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; OMEGA 3 FATTY ACID; RISPERIDONE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG POTENTIATION; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOTHERAPY; SCORING SYSTEM; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 80053047908     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05895blu     Document Type: Article

References (61)

1. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993;270(15):1819-1825. doi:10.101/jama.270.15.1819 PubMed (Pubitemid 23301435)
2. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55(7):580-592. doi:10.101/archpsyc.5.7.580 PubMed (Pubitemid 28340345)
3. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93(11):1976-1980. PubMed (Pubitemid 26165560)
4. Grippo AJ, Johnson AK. Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev. 2002;26(8):941-962. doi:10.1016/S0149-7634(03)03-4 PubMed (Pubitemid 36344034)
5. Richter N, Juckel G, Assion HJ. Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci; 2010;260(1):41-49. doi:10.107/s0406-09-013-5 PubMed
6. Kris-Etherton PM, Harris WS, Appel LJ; AHA Nutrition Committee, American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23(2):151-152. doi:10.161/01.ATV.057393.9737.AE PubMed (Pubitemid 36231919)
7. Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954-1967. doi:10.408/JCP.v67n1217 PubMed (Pubitemid 46048194)
8. Freeman MP. Omega-3 fatty acids in major depressive disorder. J Clin Psychiatry. 2009;70(suppl 5):7-11. doi:10.408/JCP.8157su1c.02 PubMed
9. Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351(9110):1213. doi:10.1016/S0140-6736(05)79168-6 PubMed
10. Maes M, Christophe A, Delanghe J, et al. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85(3):275-291. doi:10.1016/S0165-1781(9)014-1 PubMed (Pubitemid 29202389)
11. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv. 2001;52(4):529-531. doi:10.176/api.ps.52.4.529 PubMed (Pubitemid 32275317)
12. Tanskanen A, Hibbeln JR, Hintikka J, et al. Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry. 2001;58(5):512-513. doi:10.101/archpsyc.58.5.512 PubMed (Pubitemid 32411335)
13. Colin A, Reggers J, Castronovo V, et al. Lipids, depression and suicide. Encephale. 2003;29(1):49-58. PubMed (Pubitemid 36361973)
14. Clandinin MT. Brain development and assessing the supply of polyunsaturated fatty acid. Lipids. 1999;34(2):131-137. doi:10.107/s1745-9-0347- y PubMed (Pubitemid 29138310)
15. Farzaneh-Far R, Lin J, Epel ES, et al. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA. 2010;303(3):250-257. doi:10.101/jama.209.208 PubMed
16. Marchioli R, Levantesi G, Silletta MG, et al GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial. Expert Rev Cardiovasc Ther. 2009;7(7):735-748. doi:10.1586/erc.09.70 PubMed
17. Gapinski JP, VanRuiswyk JV, Heudebert GR, et al. Preventing restenosis with fish oils following coronary angioplasty: a meta-analysis. Arch Intern Med. 1993;153(13):1595-1601. doi:10.101/archinte.153.13.1595 PubMed (Pubitemid 23205859)
18. Von Schacky C. n-3 fatty acids and the prevention of coronary atherosclerosis. Am J Clin Nutr. 2000;71(suppl):224S-227S. PubMed (Pubitemid 30046120)
19. Carney RM, Freedland KE, Rubin EH, et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009;302(15):1651-1657. doi:10.101/jama.209. 1487 PubMed
20. Glassman AH, O'Connor CM, Califf RM, et al Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701-709. doi:10.101/jama.28.6.701 PubMed (Pubitemid 34848222)
21. Berkman LF, Blumenthal J, Burg M, et al Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA. 2003;289(23):3106-3116. doi:10.101/jama.289.23.3106 PubMed
22. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220. doi:10.1016/j.ypmed. 204.02.030 PubMed (Pubitemid 38797975)
23. Harris WS. The Omega-3 Index as a risk factor for coronary heart disease. Am J Clin Nutr. 2008;87(6):1997S-2002S. PubMed (Pubitemid 351872681)
24. Harris WS. The Omega-3 Index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep. 2009;11(6):411-417. doi:10.107/s183-09-062-2 PubMed
25. Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clin Biochem. 2010;43(3):338-340. doi:10.1016/j.clinbiochem.209.08.016 PubMed
26. Williams C, Birch EE, Emmett PM, et al Avon Longitudinal Study of Pregnancy and Childhood Study Team. Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. Am J Clin Nutr. 2001;73(2):316-322. PubMed (Pubitemid 32109862)
27. Koletzko B, Lien E, Agostoni C, et al World Association of Perinatal Medicine Dietary Guidelines Working Group. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14. doi:10.1515/JPM.208.01 PubMed
28. Willatts P, Forsyth JS, DiModugno MK, et al. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet. 1998;352(9129):688-691. doi:10.1016/S0140-6736(97)1374-5 PubMed (Pubitemid 28398703)
29. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric Press; 1996.
30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296. PubMed
31. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. 2006. http://www.idf.org/webdata/docs/WHO-IDF- definition-diagnosis-of-diabetes.pdf. Verified September 14, 2010.
32. International Diabetes Foundation. The IDF consensus worldwide definition of the metabolic syndrome. 2006. http://www.idf.org/webdata/docs/MetS-def- update2006.pdf. Verified September 14, 2010.
33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. doi:10.192/bjp.134.4.382 PubMed (Pubitemid 9136500)
34. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571. PubMed
35. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
36. Bonnet F, Irving K, Terra JL, et al. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens. 2005;23(3):611-617. doi:10.1097/01.hjh.0160219.71350.d2 PubMed (Pubitemid 40684720)
37. World Health Organization. The European Tobacco Control Report 2007. Copenhagen, Denmark: World Health Organization; 2007.
38. World Health Organization. The European Health Report 2009: Health and Health Systems. Copenhagen, Denmark: World Health Organization; 2009.
39. Von Schacky C. Use of red blood cell fatty-acid profiles as biomarkers in cardiac disease. Biomark Med. 2009;3(1):25-32. doi:10.217/17520363.3.1.25 PubMed
40. Parker GB, Heruc GA, Hilton TM, et al. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. Psychiatry Res. 2006;141(3):279-286. doi:10.1016/j.psychres.205.08.05 PubMed
41. Edwards R, Peet M, Shay J, et al. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998;48(2-3):149-155. doi:10.1016/S0165-0327(97)016-3 PubMed (Pubitemid 28244216)
42. Maes M, Smith R, Christophe A, et al. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord. 1996;38(1):35-46. doi:10.1016/0165-0327(95)092-5 PubMed
43. Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006;163(6):969-978. doi:10.176/api.ajp.163.6.969 PubMed (Pubitemid 44464482)
44. Peet M, Murphy B, Shay J, et al. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998;43(5):315-319. doi:10.1016/S06-323(97)0206-0 PubMed (Pubitemid 28137622)
45. Su KP, Huang SY, Chiu TH, et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2008;69(4):644-651. doi:10.408/JCP.v69n0418 PubMed (Pubitemid 351792341)
46. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003;13(4):267-271. doi:10.1016/S0924-97X(03)032-4 PubMed
47. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59(10):913-919. doi:10.101/archpsyc.59.10.913 PubMed
48. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159(3):477-479. doi:10.176/api.ajp.159.3.47 PubMed (Pubitemid 34184747)
49. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):407-412. doi:10.101/archpsyc.56.5.407 PubMed (Pubitemid 29215428)
50. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006;188(1):46-50. doi:10.192/bjp.18.1.46 PubMed (Pubitemid 43021926)
51. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160(5):996-998. doi:10.176/api.ajp.160.5.96 PubMed (Pubitemid 41079588)
52. Silvers KM, Woolley CC, Hamilton FC, et al. Randomised doubleblind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids. 2005;72(3):211-218. doi:10.1016/j.plefa.204.1.04 PubMed (Pubitemid 40139086)
53. Freeman MP, Davis M, Sinha P, et al. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord. 2008;110(1-2):142-148. doi:10.1016/j.jad.207.12.28 PubMed
54. Marangell LB, Martinez JM, Zboyan HA, et al. Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depress Anxiety. 2004;19(1):20-23. doi:10.102/da.10148 PubMed (Pubitemid 38294605)
55. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056-1061. doi:10.408/JCP.v68n0712 PubMed (Pubitemid 47340326)
56. Montgomery P, Richardson AJ. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev. 2008;(2):CD005169. PubMed
57. Kraguljac NV, Montori VM, Pavuluri M, et al. Efficacy of omega-3 fatty acids in mood disorders: a systematic review and meta-analysis. Psychopharmacol Bull. 2009;42(3):39-54. PubMed
58. Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995;62(1):1-9. PubMed
59. Leng GC, Smith FB, Fowkes FG, et al. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids. 1994;51(2):101-108. doi:10.1016/0952-3278(94)9085-X PubMed (Pubitemid 24240587)
60. Leng GC, Horrobin DF, Fowkes FG, et al. Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study. Arterioscler Thromb. 1994;14(3):471-478. PubMed
61. Leonard BE, Myint A. The psychoneuroimmunology of depression. Hum Psychopharmacol. 2009;24(3):165-175.